← Back to directory

Gabriel Capellá

Researcher Next ID · RN-035413

Researcher · Biochemistry, Genetics and Molecular Biology

Department of Natural and Environmental Resources

San Juan, Spain

Accepting doctoral researchersFunding unknown
Works count
707
Citation count
28,224
H-index
81
i10-index
319

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Genetic factors in colorectal cancer
Cancer Genomics and Diagnostics
Colorectal Cancer Treatments and Studies
Colorectal Cancer Screening and Detection
Genomics and Rare Diseases

Publications

  • Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

    The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00189-3

  • Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

    Genetics in Medicine · 2019 · https://doi.org/10.1038/s41436-019-0596-9

  • Cancer Risks for PMS2 -Associated Lynch Syndrome

    Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.78.4777

  • Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

    Gut · 2017 · https://doi.org/10.1136/gutjnl-2017-314057

  • POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance

    Genetics in Medicine · 2015 · 10.1038/gim.2015.75

  • Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database

    Gut · 2015 · https://doi.org/10.1136/gutjnl-2015-309675

  • Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

    Nature Genetics · 2013 · https://doi.org/10.1038/ng.2854

  • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

    Gut · 2013 · https://doi.org/10.1136/gutjnl-2012-304356

  • Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition

    International Journal of Cancer · 2013 · https://doi.org/10.1002/ijc.28387

  • A DNA methylation fingerprint of 1628 human samples

    Genome Research · 2011 · https://doi.org/10.1101/gr.119867.110

  • Peutz–Jeghers syndrome: a systematic review and recommendations for management

    Gut · 2010 · https://doi.org/10.1136/gut.2009.198499

  • Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.30.1077

  • Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer

    Proceedings of the National Academy of Sciences · 2009 · 10.1073/pnas.0813221106

  • The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

    Genome Research · 2009 · https://doi.org/10.1101/gr.083550.108

  • A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function

    Nature Genetics · 2009 · 10.1038/ng.317

  • Recent Advances in Cancer Therapy: An Overview

    Current Pharmaceutical Design · 2009 · https://doi.org/10.2174/138161210789941847

  • Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21

    Nature Genetics · 2008 · https://doi.org/10.1038/ng.133

  • Guidelines for the clinical management of familial adenomatous polyposis (FAP)

    Gut · 2008 · https://doi.org/10.1136/gut.2007.136127

  • Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

    Journal of Medical Genetics · 2007 · https://doi.org/10.1136/jmg.2007.048991

  • Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

    Clinical Cancer Research · 2006 · 10.1158/1078-0432.ccr-05-1363

  • Chromosomal Instability Correlates with Genome-wide DNA Demethylation in Human Primary Colorectal Cancers

    Cancer Research · 2006 · 10.1158/0008-5472.can-06-0293

  • Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.

    PubMed · 2003

  • Genetic susceptibility and gastric cancer risk

    International Journal of Cancer · 2002 · 10.1002/ijc.10466

  • Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.

    PubMed · 2001

  • Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

    PubMed · 2000

  • Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.

    PubMed · 2000

  • Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.

    PubMed · 2000

  • K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance

    Journal of Clinical Oncology · 1999 · https://doi.org/10.1200/jco.1999.17.2.578

Current projects

    No projects listed.